The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood–testis barrier and in primary testicular tumours
- 30 September 2004
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 40 (14), 2064-2070
- https://doi.org/10.1016/j.ejca.2004.05.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic reviewCancer Treatment Reviews, 2002
- An oncological view on the blood–testis barrierThe Lancet Oncology, 2002
- Childhood acute lymphoblastic leukaemia – current status and future perspectivesThe Lancet Oncology, 2001
- Primary Large-Cell Non-Hodgkin's Lymphoma of the Testis: A Retrospective Analysis of Patterns of Failure and Prognostic FactorsClinical Lymphoma, 2001
- A Family of Drug Transporters: the Multidrug Resistance-Associated ProteinsJNCI Journal of the National Cancer Institute, 2000
- Delayed Orchiectomy After Chemotherapy for Metastatic Nonseminomatous Germ Cell TumorsJournal of Urology, 1996
- Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?Cancer, 1995
- Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: A 10-year follow-up studyMedical and Pediatric Oncology, 1995
- Testicular relapse in adult acute lymphocytic leukemia: A case report and literature reviewMedical and Pediatric Oncology, 1989